[1] It is intended for individuals with obesity, typically defined as a BMI of 30 kg/m or 27 kg/m with weight-related comorbidities, and is prescribed alongside dietary modifications and exercise
However, it is also recognized that levels of this antioxidant normally decline as we age
This results in preventing the progression of osteoporosis and thereby leads to an overall less progression of bone loss
However, these effects were observed in prostate cancer cells and prostate tissue, and not examined in the context of hair loss
Keywords : Anti-obesity agents
In addition to their inhibitory effects, at both low and high doses, somatostatin stimulates the secretion of GH in primary porcine somatotrophs (81, 88)